Completed NA INTERVENTIONAL 2-arm NCT04686760

Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

Efficacy of Inhaled Nitroglycerin in Moderate to Severe Cases of COVID-19 Patients

Sponsor: University of Lahore

Updated 5 times since 2021 Last updated: May 16, 2022 Started: Nov 15, 2020 Primary completion: Dec 15, 2021 Completion: Mar 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Corona Virus Infection, this trial is completed. The trial is conducted by University of Lahore and has accumulated 5 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2021 — Jun 2022 [monthly]

Recruiting NA
Jan 2021 — Jun 2021 [monthly]

Recruiting NA

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Lahore

Data source: University of Lahore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lahore, Pakistan